Neogenomics Inc (NEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 228,713 | 173,016 | 9,811 | 12,821 | 12,525 |
| Marketable Securities | 67,546 | 0 | N/A | N/A | N/A |
| Receivables | 106,843 | 94,242 | 76,919 | 60,427 | 55,512 |
| Inventories | 29,526 | 14,405 | 8,650 | 7,474 | 6,253 |
| Other current assets | 4,555 | 2,748 | 561 | 1,001 | 4,535 |
| TOTAL | $448,730 | $290,738 | $103,668 | $85,875 | $78,825 |
| Non-Current Assets | |||||
| PPE Net | 85,873 | 64,188 | 60,888 | 36,504 | 34,036 |
| Investments And Advances | 29,555 | 0 | 0 | 0 | 0 |
| Intangibles | 331,736 | 325,241 | 337,921 | 221,184 | 224,083 |
| Other Non-Current Assets | 92,437 | 29,339 | 2,538 | 891 | 174 |
| TOTAL | $539,601 | $418,768 | $401,347 | $258,579 | $258,293 |
| Total Assets | $988,331 | $709,506 | $505,015 | $344,454 | $337,118 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 5,000 | 7,873 | 3,799 | 3,842 |
| Accounts payable and accrued liabilities | 24,965 | 19,568 | 17,779 | 10,450 | 16,782 |
| Accrued Expenses | 36,381 | 28,913 | 28,048 | 15,626 | 12,598 |
| Other current liabilities | 4,029 | 1,610 | 927 | 1,406 | N/A |
| TOTAL | $73,183 | $63,904 | $60,925 | $36,471 | $38,113 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 91,829 | 92,880 | 91,152 | 92,058 |
| Other Non-Current Liabilities | 214,472 | 27,600 | 3,060 | 32,898 | 22,873 |
| TOTAL | $220,854 | $138,194 | $123,647 | $136,021 | $135,282 |
| Total Liabilities | $294,037 | $202,098 | $184,572 | $172,492 | $173,395 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 116,940 | 104,832 | 94,566 | 80,507 | 78,823 |
| Common Shares | 112 | 105 | 94 | 80 | 79 |
| Retained earnings | -7,185 | -11,357 | -19,363 | -58,422 | -52,460 |
| Other shareholders' equity | 10 | -1,618 | -579 | 274 | 0 |
| TOTAL | $694,294 | $507,408 | $320,443 | $171,962 | $163,723 |
| Total Liabilities And Equity | $988,331 | $709,506 | $505,015 | $344,454 | $337,118 |